About this episode
If you were told you had months, weeks or even days left to live...would you care what the law said about consuming psychoactive substances? This week’s episode features Spencer Hawkswell the CEO of TheraPsil - a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy to treat end-of-life distress.
Spencer believes that responsible drug policy requires effective organization and leadership and is dedicated to bringing together the experts and advocates, to facilitate change that results in increased access to compassionate care, harm reduction, and treatment options for those in need.
Tune in to this week’s episode to hear how the Land of Maple Leaf implements its patient-centred approach in healthcare. What happened in the UK? Are there lessons to be learnt from Canada?
Re: Proposed Regulations for Medical Access to Psilocybin
Get every episode summarized
Each time The Drug Science Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Drug Science Podcast
158. The Story of Pharmacology with Prof Rod Flower
The Drug Science Podcast
157. Psychedelics and Christianity with Wendi Rees
The Drug Science Podcast
156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda
The Drug Science Podcast
155. The History of Schizophrenia with Justin Garson
The Drug Science Podcast